Dimensional Fund Advisors’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.5M | Buy |
997,759
+75,862
| +8% | +$2.59M | 0.01% | 1791 |
|
|
2025
Q4 | $36.5M | Buy |
921,897
+71,341
| +8% | +$2.62M | 0.01% | 1675 |
|
|
2025
Q3 | $30M | Buy |
850,556
+30,448
| +4% | +$1.05M | 0.01% | 1796 |
|
|
2025
Q2 | $26.9M | Buy |
820,108
+109,064
| +15% | +$3.54M | 0.01% | 1830 |
|
|
2025
Q1 | $22.9M | Buy |
711,044
+10,832
| +2% | +$402K | 0.01% | 1878 |
|
|
2024
Q4 | $21.4M | Buy |
700,212
+136,015
| +24% | +$4.37M | 0.01% | 1968 |
|
|
2024
Q3 | $15.8M | Sell |
564,197
-141,502
| -20% | -$3.49M | ﹤0.01% | 2104 |
|
|
2024
Q2 | $16.1M | Sell |
705,699
-274,740
| -28% | -$6.34M | ﹤0.01% | 2065 |
|
|
2024
Q1 | $29.8M | Sell |
980,439
-20,722
| -2% | -$694K | 0.01% | 1782 |
|
|
2023
Q4 | $35.7M | Buy |
1,001,161
+9,176
| +0.9% | +$341K | 0.01% | 1664 |
|
|
2023
Q3 | $43.4M | Buy |
991,985
+78,353
| +9% | +$3.82M | 0.01% | 1443 |
|
|
2023
Q2 | $45.1M | Buy |
913,632
+57,528
| +7% | +$2.65M | 0.01% | 1431 |
|
|
2023
Q1 | $35.5M | Buy |
856,104
+253,419
| +42% | +$10.5M | 0.01% | 1585 |
|
|
2022
Q4 | $26.7K | Sell |
602,685
-93,427
| -13% | -$3.9M | 0.01% | 1709 |
|
|
2022
Q3 | $27.2M | Sell |
696,112
-72,076
| -9% | -$3.3M | 0.01% | 1644 |
|
|
2022
Q2 | $31.4M | Buy |
768,188
+51,063
| +7% | +$2.42M | 0.01% | 1605 |
|
|
2022
Q1 | $47.1M | Buy |
717,125
+46,705
| +7% | +$3.03M | 0.01% | 1454 |
|
|
2021
Q4 | $46.6M | Sell |
670,420
-8,140
| -1% | -$592K | 0.01% | 1459 |
|
|
2021
Q3 | $47.2M | Buy |
678,560
+88,370
| +15% | +$6.8M | 0.02% | 1457 |
|
|
2021
Q2 | $46.8M | Buy |
590,190
+169,957
| +40% | +$12.4M | 0.01% | 1505 |
|
|
2021
Q1 | $27.5M | Buy |
420,233
+136,044
| +48% | +$8.38M | 0.01% | 1865 |
|
|
2020
Q4 | $15.8M | Buy |
284,189
+29,179
| +11% | +$1.26M | 0.01% | 2088 |
|
|
2020
Q3 | $10.2M | Buy |
255,010
+10,545
| +4% | +$447K | ﹤0.01% | 2182 |
|
|
2020
Q2 | $11M | Buy |
244,465
+39,330
| +19% | +$1.71M | ﹤0.01% | 2161 |
|
|
2020
Q1 | $6.89M | Buy |
205,135
+23,717
| +13% | +$853K | ﹤0.01% | 2279 |
|
|
2019
Q4 | $5.9M | Buy |
181,418
+49,629
| +38% | +$1.41M | ﹤0.01% | 2554 |
|
|
2019
Q3 | $3.29M | Buy |
131,789
+85,527
| +185% | +$2.44M | ﹤0.01% | 2726 |
|
|
2019
Q2 | $1.38M | Buy |
+46,262
| New | +$1.35M | ﹤0.01% | 2984 |
|
|
2015
Q1 | – | Sell |
-23,675
| Closed | -$473K | – | 3336 |
|
|
2014
Q4 | $473K | Sell |
23,675
-2,733
| -10% | -$46.9K | ﹤0.01% | 3141 |
|
|
2014
Q3 | $389K | Hold |
26,408
| – | – | ﹤0.01% | 3186 |
|
|
2014
Q2 | $485K | Sell |
26,408
-14,896
| -36% | -$248K | ﹤0.01% | 3195 |
|
|
2014
Q1 | $777K | Hold |
41,304
| – | – | ﹤0.01% | 3093 |
|
|
2013
Q4 | $772K | Hold |
41,304
| – | – | ﹤0.01% | 3081 |
|
|
2013
Q3 | $454K | Sell |
41,304
-12,014
| -23% | -$118K | ﹤0.01% | 3205 |
|
|
2013
Q2 | $507K | Buy |
+53,318
| New | +$465K | ﹤0.01% | 3173 |
|
Other funds holding ATRC
HRCM
VPM
VCM
NAMI
Dimensional Fund Advisors's ATRC Position: Q1 2026 in Review
Dimensional Fund Advisors increased its AtriCure (ATRC) stake by 8.2% in Q1 2026, buying an estimated $2.59M and bringing the position to 997,759 shares worth $28.5M. The position accounts for 0.01% of the portfolio, ranked #1791.
Dimensional Fund Advisors first reported a position in ATRC in Q2 2013 and has held it in 35 quarters since. The position peaked at $47.2M in Q3 2021. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.
- Dimensional Fund Advisors held 997,759 shares of AtriCure worth $28.5M as of Q1 2026.
- Dimensional Fund Advisors bought 75,862 AtriCure shares in Q1 2026, an estimated $2.59M.
- AtriCure made up 0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #1791 holding.
- Dimensional Fund Advisors first reported a position in AtriCure in Q2 2013 and has held it in 35 quarters since.
- Dimensional Fund Advisors's AtriCure position peaked at $47.2M in Q3 2021.
- 223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.